Understanding the role of tariquidar, a potent Pgp inhibitor, in combination trials with cytotoxic drugs: What is missing?
Crossref DOI link: https://doi.org/10.1007/s00280-016-3044-4
Published Online: 2016-05-13
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Srinivas, Nuggehally R.
Text and Data Mining valid from 2016-05-13
